| Vaccine adjuvants as potential cancer immunotherapeutics B Temizoz, E Kuroda, KJ Ishii International immunology 28 (7), 329-338, 2016 | 240 | 2016 |
| MafB is essential for renal development and F4/80 expression in macrophages T Moriguchi, M Hamada, N Morito, T Terunuma, K Hasegawa, C Zhang, ... Molecular and cellular biology 26 (15), 5715-5727, 2006 | 231 | 2006 |
| Silica crystals and aluminum salts regulate the production of prostaglandin in macrophages via NALP3 inflammasome-independent mechanisms E Kuroda, KJ Ishii, S Uematsu, K Ohata, C Coban, S Akira, K Aritake, ... Immunity 34 (4), 514-526, 2011 | 230 | 2011 |
| Regulation of macrophage-derived chemokine (MDC/CCL22) production U Yamashita, E Kuroda Critical Reviews™ in Immunology 22 (2), 2002 | 169 | 2002 |
| Mechanisms of enhanced macrophage-mediated prostaglandin E2 production and its suppressive role in Th1 activation in Th2-dominant BALB/c mice E Kuroda, U Yamashita The Journal of Immunology 170 (2), 757-764, 2003 | 156 | 2003 |
| Generation and characterization of murine alternatively activated macrophages SB Weisser, KW McLarren, E Kuroda, LM Sly Basic cell culture protocols, 225-239, 2013 | 148 | 2013 |
| Brief communication immunomodulating activity of seaweed extract on human lymphocytes in vitro BE Shan, Y Yoshida, E Kuroda, U Yamashita International journal of immunopharmacology 21 (1), 59-70, 1999 | 144 | 1999 |
| Nonagonistic Dectin-1 ligand transforms CpG into a multitask nanoparticulate TLR9 agonist K Kobiyama, T Aoshi, H Narita, E Kuroda, M Hayashi, K Tetsutani, ... Proceedings of the National Academy of Sciences 111 (8), 3086-3091, 2014 | 139 | 2014 |
| TLR9 and STING agonists synergistically induce innate and adaptive type‐II IFN B Temizoz, E Kuroda, K Ohata, N Jounai, K Ozasa, K Kobiyama, T Aoshi, ... European journal of immunology 45 (4), 1159-1169, 2015 | 134 | 2015 |
| Particulate adjuvant and innate immunity: past achievements, present findings, and future prospects E Kuroda, C Coban, KJ Ishii International reviews of immunology 32 (2), 209-220, 2013 | 129 | 2013 |
| SHIP represses the generation of IL-3-induced M2 macrophages by inhibiting IL-4 production from basophils E Kuroda, V Ho, J Ruschmann, F Antignano, M Hamilton, MJ Rauh, ... The Journal of Immunology 183 (6), 3652-3660, 2009 | 128 | 2009 |
| Pulmonary toxicity of well-dispersed multi-wall carbon nanotubes following inhalation and intratracheal instillation Y Morimoto, M Hirohashi, A Ogami, T Oyabu, T Myojo, M Todoroki, ... Nanotoxicology 6 (6), 587-599, 2012 | 125 | 2012 |
| Sensitivity difference to the suppressive effect of prostaglandin E2 among mouse strains: a possible mechanism to polarize Th2 type response in BALB/c mice E Kuroda, T Sugiura, K Zeki, Y Yoshida, U Yamashita The Journal of Immunology 164 (5), 2386-2395, 2000 | 125 | 2000 |
| Inhaled fine particles induce alveolar macrophage death and interleukin-1α release to promote inducible bronchus-associated lymphoid tissue formation E Kuroda, K Ozasa, B Temizoz, K Ohata, CX Koo, T Kanuma, T Kusakabe, ... Immunity 45 (6), 1299-1310, 2016 | 124 | 2016 |
| MafB promotes atherosclerosis by inhibiting foam-cell apoptosis M Hamada, M Nakamura, MTN Tran, T Moriguchi, C Hong, T Ohsumi, ... Nature communications 5 (1), 3147, 2014 | 124 | 2014 |
| A proximal κB site in the IL-23 p19 promoter is responsible for RelA-and c-Rel-dependent transcription S Mise-Omata, E Kuroda, J Niikura, U Yamashita, Y Obata The Journal of Immunology 179 (10), 6596-6603, 2007 | 105 | 2007 |
| Prostaglandin E2 up-regulates macrophage-derived chemokine production but suppresses IFN-inducible protein-10 production by APC E Kuroda, T Sugiura, K Okada, K Zeki, U Yamashita The Journal of Immunology 166 (3), 1650-1658, 2001 | 98 | 2001 |
| Comparison of pulmonary inflammatory responses following intratracheal instillation and inhalation of nanoparticles Y Morimoto, H Izumi, Y Yoshiura, T Tomonaga, BW Lee, T Okada, ... Nanotoxicology 10 (5), 607-618, 2016 | 86 | 2016 |
| Cutaneous hypersensitivities to hapten are controlled by IFN-γ-upregulated keratinocyte Th1 chemokines and IFN-γ-downregulated langerhans cell Th2 chemokines T Mori, K Kabashima, R Yoshiki, K Sugita, N Shiraishi, A Onoue, E Kuroda, ... Journal of Investigative Dermatology 128 (7), 1719-1727, 2008 | 84 | 2008 |
| Reduced expression of STAT4 and IFN-γ in macrophages from BALB/c mice E Kuroda, T Kito, U Yamashita The Journal of Immunology 168 (11), 5477-5482, 2002 | 83 | 2002 |
